Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CADI-R703 is a research and discovery program developed by Bio-Modeling Systems (BMSystems) utilizing its proprietary CADI™ (Computer Assisted Deductive Integration) platform. The program is specifically focused on elucidating the complex biological mechanisms underlying skin aging to identify novel targets for dermatological and cosmetic applications. Unlike traditional high-throughput screening, the CADI™ approach employs a heuristic biological modeling platform to integrate heterogeneous data and map systems-level interactions. As of the current reporting, the program is in the discovery phase, with the initial biological model completed ('Produced') and available for collaborative development to identify specific therapeutic protocols or active ingredients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CADI-R703.